檢索結果 - Maria I. Carlo

Refine Results
  1. 1
    Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis

    Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis 由 Maria I. Carlo, Darren R. Feldman

    出版 2016
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  2. 2
    Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma

    Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma 由 Maria I. Carlo, Martin H. Voss, Robert J. Motzer

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer

    Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer 由 James J. Hsieh, Brandon J. Manley, Nabeela Khan, Jianjiong Gao, Maria I. Carlo, Emily H. Cheng

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma

    A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma 由 Maria I. Carlo, Ana M. Molina, Yulia Lakhman, Sujata Patil, Kaitlin M. Woo, John DeLuca, Chung‐Han Lee, James J. Hsieh, Darren R. Feldman, Robert J. Motzer, Martin H. Voss

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes

    Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes 由 Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Mark T.A. Donoghue, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Martin H. Voss, Robert J. Motzer

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights

    Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights 由 Maria I. Carlo, A. Ari Hakimi, Grant D. Stewart, Gennady Bratslavsky, James Brugarolas, Ying‐Bei Chen, W. Marston Linehan, Eamonn R. Maher, Maria J. Merino, Kenneth Offit, Victor E. Reuter, Brian Shuch, Jonathan Coleman

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes

    Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes 由 Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Jozefina Casuscelli, Almedina Redzematovic, Renzo G. DiNatale, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Robert J. Motzer, Martin H. Voss

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes

    Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes 由 Maria I. Carlo, Joshua Chaim, Sujata Patil, Yelena Kemel, Alison M. Schram, Kaitlin M. Woo, Devyn Taylor Coskey, Gouri J. Nanjangud, Martin H. Voss, Darren R. Feldman, James J. Hsieh, A. Ari Hakimi, Ying‐Bei Chen, Robert J. Motzer, Chung‐Han Lee

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases

    Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases 由 Liwei Jia, Maria I. Carlo, Hina Khan, Gouri J. Nanjangud, Satshil Rana, Robert Cimera, Yanming Zhang, A. Ari Hakimi, Amit Verma, Hikmat Al‐Ahmadie, Samson W. Fine, Anuradha Gopalan, S. Joseph Sirintrapun, Satish K. Tickoo, Victor E. Reuter, Benjamin A. Gartrell, Ying‐Bei Chen

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

    Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma 由 Maria I. Carlo, Brandon J. Manley, Sujata Patil, Kaitlin M. Woo, Devyn Taylor Coskey, Almedina Redzematovic, Maria E. Arcila, Marc Ladanyi, Won-Jae Lee, Ying‐Bei Chen, Chung‐Han Lee, Darren R. Feldman, A. Ari Hakimi, Robert J. Motzer, James J. Hsieh, Martin H. Voss

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy

    DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy 由 Yasser Ged, Joshua Chaim, Renzo G. DiNatale, Andrea Knežević, Ritesh R. Kotecha, Maria I. Carlo, Chung‐Han Lee, Ashley A. Foster, Darren R. Feldman, Min Yuen Teo, Gopa Iyer, Timothy A. Chan, Sujata Patil, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations

    Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations 由 Diana Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, Joshua Somar, Miika Mehine, Maksym Misyura, Olca Baştürk, Alicia Latham, Maria I. Carlo, Michael F. Walsh, Zsofia K. Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge S. Reis‐Filho, Ozge Ceyhan‐Birsoy

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

    Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders 由 Alice Boilève, Maria I. Carlo, Philippe Barthélémy, Stéphane Oudard, Delphine Borchiellini, Martin H. Voss, Saby George, Christine Chevreau, Judith Landman‐Parker, M-D Tabone, D. D. Chism, A. Amin, Mehmet Asım Bilen, Dominick Bossé, Aurore Coulomb‐L'Herminé, Xiaoping Su, Toni K. Choueiri, Nizar M. Tannir, Gabriel G. Malouf

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy

    Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy 由 Maria I. Carlo, Kyrollis Attalla, Yousef Mazaheri, Sounak Gupta, Onur Yıldırım, Samuel Murray, Devyn Taylor Coskey, Ritesh R. Kotecha, Chung‐Han Lee, Darren R. Feldman, Paul Russo, Sujata Patil, Robert J. Motzer, Jonathan Coleman, Jeremy C. Durack, Ying‐Bei Chen, Oğuz Akın, A. Ari Hakimi, Martin H. Voss

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates 由 Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Ying‐Bei Chen, Mark Zucker, Andrea Knežević, Robert A. Lefkowitz, Natalie Shapnik, Chloe Dadoun, Ed Reznik, Neil J. Shah, Colette Owens, Deaglan Joseph McHugh, David H. Aggen, Andrew Leonard Laccetti, Ritesh R. Kotecha, Darren R. Feldman, Robert J. Motzer

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers 由 Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley Marie Regazzi, Brooke Kania, Meredith Moran, C Cipolla, Mark J. Bluth, Joshua Chaim, Hikmat Al‐Ahmadie, Alexandra Snyder, Maria I. Carlo, David B. Solit, Michael F. Berger, Samuel A. Funt, Jedd D. Wolchok, Gopa Iyer, Dean F. Bajorin, Margaret K. Callahan, Jacob Rosenberg

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

    Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing 由 Panieh Terraf, Fresia Pareja, David Brown, Ozge Ceyhan‐Birsoy, Maksym Misyura, Satshil Rana, Eileen M. O’Reilly, Maria I. Carlo, Carol Aghajanian, Ying L. Liu, Fatemeh Derakhshan, Gowtham Jayakumaran, Britta Weigelt, Michael F. Walsh, Zsofia K. Stadler, Kenneth Offit, Marc Ladanyi, Mark E. Robson, Ahmet Zehir, Jorge S. Reis‐Filho, Diana Mandelker

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma

    Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma 由 Jozefina Casuscelli, Maria F. Becerra, Brandon J. Manley, Emily C. Zabor, Ed Reznik, Almedina Redzematovic, Maria E. Arcila, Daniel Tennenbaum, Mazyar Ghanaat, Mahyar Kashan, Christian G. Stief, Maria I. Carlo, Martin H. Voss, Darren R. Feldman, Robert J. Motzer, Ying‐Bei Chen, Victor E. Reuter, Jonathan Coleman, Paul Russo, James J. Hsieh, A. Ari Hakimi

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma

    Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma 由 Jack P. Gleeson, Ines Nikolovski, Renzo G. DiNatale, Mark Zucker, Andrea Knežević, Sujata Patil, Yasser Ged, Ritesh R. Kotecha, Natalie Shapnik, Samuel Murray, Paul Russo, Jonathan Coleman, Chung‐Han Lee, Zsofia K. Stadler, A. Ari Hakimi, Darren R. Feldman, Robert J. Motzer, Ed Reznik, Martin H. Voss, Ying‐Bei Chen, Maria I. Carlo

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer

    Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer 由 Jada G. Hamilton, Heather Symecko, Kelsey Spielman, Kelsey Breen, Rebecca Mueller, Amanda Catchings, Magan Trottier, Erin Salo‐Mullen, Ibrahim H. Shah, A. B. Arutyunova, Melissa Batson, Rebecca Gebert, Stacy Pundock, Elizabeth Schofield, Kenneth Offit, Zsofia K. Stadler, Karen A. Cadoo, Maria I. Carlo, Vivek Narayan, Kim A. Reiss, Mark E. Robson, Susan M. Domchek

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: